ICU: מכפיל P/E SeaStar Medical Holding Corp.

SeaStar Medical Holding develops an advanced blood filtration solution to assist in cases of critical organ failure. The company's environmental policy is based on strict compliance with medical waste disposal regulations. The production cycle relies on contract manufacturing organizations (CMO), while the intellectual property remains with the brand. This price action chart shows that the current figure is -0.30.
פילוחים אנליטיים של חברת SeaStar Medical Holding (ICU)

SeaStar Medical Holding's dependence on global supply chains and patent risks directly impacts net income, driving multiplier volatility. This ratio reflects the business value relative to its annual earnings, allowing for an assessment of whether the asset is overvalued or undervalued through the company's P/E history, where the balance between yield and the risk of capital freeze determines market expectations.